PLEKHM1P expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.662000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.743200E-01
Normal-vs-Stage2
9.580800E-01
Normal-vs-Stage3
9.350800E-01
Normal-vs-Stage4
9.656000E-01
Stage1-vs-Stage2
6.344600E-01
Stage1-vs-Stage3
8.925000E-01
Stage1-vs-Stage4
7.993200E-01
Stage2-vs-Stage3
8.287200E-01
Stage2-vs-Stage4
8.975600E-01
Stage3-vs-Stage4
9.573000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.382000E-01
Normal-vs-AfricanAmerican
9.188200E-01
Normal-vs-Asian
8.269000E-01
Caucasian-vs-AfricanAmerican
7.683400E-01
Caucasian-vs-Asian
5.434200E-01
AfricanAmerican-vs-Asian
8.955800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.857800E-01
Normal-vs-Female
9.276000E-01
Male-vs-Female
8.037400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.427400E-01
Normal-vs-Age(41-60Yrs)
9.551000E-01
Normal-vs-Age(61-80Yrs)
9.374400E-01
Normal-vs-Age(81-100Yrs)
8.034600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.533000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.653800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.771200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.111400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.825000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.585000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.685400E-01
Normal-vs-Daily Drinker
6.076600E-01
Normal-vs-Weekly Drinker
8.717600E-01
Normal-vs-Occasional Drinker
9.314800E-01
Normal-vs-Social Drinker
7.613600E-01
Non Drinker-vs-Daily Drinker
4.012000E-01
Non Drinker-vs-Weekly Drinker
6.987000E-01
Non Drinker-vs-Occasional Drinker
9.311000E-01
Non Drinker-vs-Social Drinker
4.644000E-01
Daily Drinker-vs-Weekly Drinker
4.665200E-01
Daily Drinker-vs-Occasional Drinker
4.521200E-01
Daily Drinker-vs-Social Drinker
1.727380E-01
Weekly Drinker-vs-Occasional Drinker
6.723200E-01
Weekly Drinker-vs-Social Drinker
9.986800E-01
Occasional Drinker-vs-Social Drinker
4.410600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.691200E-01
Normal-vs-Grade 2
8.666200E-02
Normal-vs-Grade 3
1.620770E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.156300E-02
Grade 1-vs-Grade 3
1.922140E-02
Grade 1-vs-Grade 4
2.691200E-01
Grade 2-vs-Grade 3
4.020200E-01
Grade 2-vs-Grade 4
8.666200E-02
Grade 3-vs-Grade 4
1.620770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.227000E-01
Normal-vs-NonDiabetic
9.935600E-01
Diabetic-vs-NonDiabetic
7.246400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.711200E-01
Normal-vs-NoPancreatitis
8.635000E-01
Pancreatitis-vs-NoPancreatitis
6.900400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.444400E-01
Normal-vs-N1
9.471200E-01
N0-vs-N1
6.479800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.879400E-01
Normal-vs-TP53-NonMutant
9.434600E-01
TP53-Mutant-vs-TP53-NonMutant
6.554200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
